Page last updated: 2024-11-05

ticlopidine and Carcinoma, Basal Cell, Pigmented

ticlopidine has been researched along with Carcinoma, Basal Cell, Pigmented in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alam, M1
Goldberg, LH1

Other Studies

1 other study available for ticlopidine and Carcinoma, Basal Cell, Pigmented

ArticleYear
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:11

    Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Fem

2002